Loading...
•
Sep 30, 2020
ResMed Q1 2021 Earnings Report
ResMed's first quarter results reflected solid performance with revenue growth and profitability improvements.
Key Takeaways
ResMed Inc. reported a 10% increase in revenue to $751.9 million and a 24% increase in non-GAAP operating profit for the first quarter of fiscal year 2021. The company continued to support the global COVID-19 pandemic response and saw sequential improvement in new patient volume in core markets.
Revenue increased by 10% year-over-year to $751.9 million.
Non-GAAP operating profit increased by 24% year-over-year.
GAAP diluted earnings per share were $1.22, while non-GAAP diluted earnings per share were $1.27.
The company supported the global COVID-19 pandemic response with ventilators, masks, and circuits.
ResMed
ResMed
Forward Guidance
No specific forward guidance was provided in the earnings report.